Soleno Therapeutics Inc Capital Reinvestment Ratio
Soleno Therapeutics Inc capital reinvestment ratio. Soleno Therapeutics Inc (SLNO) has a Capital Reinvestment Ratio of 0.00x as of March 2026, meaning it reinvests 0% of its operating cash flow ($25.98 Million) in capital expenditures ($40.00K). Check cash flow reinvestment rate of Soleno Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Soleno Therapeutics Inc (2025–2025)
Capital reinvestment ratio of Soleno Therapeutics Inc from 2025 to 2025. This chart tracks Soleno Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore Soleno Therapeutics Inc (SLNO) net asset momentum to track the company's year-over-year net asset growth rate.
Soleno Therapeutics Inc Capital Reinvestment Ratio by Year (2025–2025)
Soleno Therapeutics Inc capital reinvestment ratio by year from 2025 to 2025. For the full cash flow conversion analysis, see SLNO cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | $46.80 Million | $73.00K | — |